Your browser doesn't support javascript.
loading
CCR5 status and metastatic progression in colorectal cancer.
Suarez-Carmona, Meggy; Chaorentong, Pornpimol; Kather, Jakob Nikolas; Rothenheber, Rebecca; Ahmed, Azaz; Berthel, Anna; Heinzelmann, Anita; Moraleda, Rodrigo; Valous, Nektarios A; Kosaloglu, Zeynep; Eurich, Rosa; Wolf, Jana; Grauling-Halama, Silke; Hundemer, Michael; Lasitschka, Felix; Klupp, Fee; Kahlert, Christoph; Ulrich, Alexis; Schneider, Martin; Falk, Christine; Jäger, Dirk; Zoernig, Inka; Halama, Niels.
Afiliación
  • Suarez-Carmona M; Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chaorentong P; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Kather JN; Helmholtz Center for Translational Oncology (HITRON), Mainz, Germany.
  • Rothenheber R; Clinical Cooperation Unit Applied Tumor Immunity, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Ahmed A; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Berthel A; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Heinzelmann A; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Moraleda R; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Valous NA; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Kosaloglu Z; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Eurich R; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Wolf J; Clinical Cooperation Unit Applied Tumor Immunity, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Grauling-Halama S; Clinical Cooperation Unit Applied Tumor Immunity, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Hundemer M; Clinical Cooperation Unit Applied Tumor Immunity, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Lasitschka F; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Klupp F; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Kahlert C; Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ulrich A; Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Schneider M; Helmholtz Center for Translational Oncology (HITRON), Mainz, Germany.
  • Falk C; Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany.
  • Jäger D; Institute for Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Zoernig I; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Halama N; Department of Surgery, University Hospital Dresden, Dresden, Germany.
Oncoimmunology ; 8(9): e1626193, 2019.
Article en En | MEDLINE | ID: mdl-31428524
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2019 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2019 Tipo del documento: Article País de afiliación: Alemania